000			03385nam a2200409 i 4500
999			_c112559 _d112559
001			112559
003			ES-MaUEC
005			20230130125914.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			180731s2019 si a o |||| 0|eng d
020			_a9789811045486
024	7		_a10.1007/978-981-10-4548-6 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC849 _b2019 EB
245	0	0	_aIgG4-Related Sclerosing Cholangitis _cedited by Terumi Kamisawa, Myung-Hwan Kim
264		1	_aSingapore _bSpringer Singapore _c2019
300			_a1 recurso en línea (VIII, 142 páginas) _b54 ilustraciones, 34 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aO verview including classification of sclerosing cholangitis -- Epidemiology -- Pathophysiology -- Pathology -- Clinical features -- Serology -- Diagnostic criteria -- Imaging -- 1) US and CT -- 2) MRI with MRCP -- 3) ERCP -- 4) EUS and IDUS -- Differential diagnosis from primarysclerosing cholangitis -- Differential diagnosis from cholangiocarcinoma -- Tissue acquisition for histologic diagnosis -- Other organ involvements including autoimmune pancreatitis -- Treatment -- 1) Steroids -- 2) Immunomodulatory drugs -- 3) Rituximab -- Prognosis -- IgG4-related sclerosing cholangitis in America -- IgG4-related sclerosing cholangitis in Europe -- IgG4-related disease.
520	3		_aThis book aims to raise awareness of IgG4-related sclerosing cholangitis among practicing physicians and to equip readers with a sound understanding of the principles of diagnosis and treatment. Clinical, serological, and histopathological features are clearly described and imaging appearances on all relevant modalities are illustrated, covering the bile duct and other involved organs. Differential diagnosis from other diseases, including primary sclerosing cholangitis and cholangiocarcinoma, is precisely explained. Information is then presented on all significant current and emerging therapeutic strategies, including steroids, immunosuppressive drugs, and rituximab. Finally, attention is drawn to significant prognostic features. While IgG4-related sclerosing cholangitis is now a widely acknowledged condition, most practitioners are still liable to misdiagnose it owing to a lack of familiarity with its presenting features. This book should help to rectify the situation and will be an asset for all who may encounter the disease in clinical practice.
988			_aSpringer_Medicine_2019
650		7	_aVesícula biliar _2embne _9676621 _xEnfermedades
700	1		_aKamisawa, Terumi. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt _995517
700	1		_aKim, Myung-Hwan. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _9106996
776	0	8	_iPrinted edition: _z9789811045479
776	0	8	_iPrinted edition: _z9789811045493
776	0	8	_iPrinted edition: _z9789811338397
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-10-4548-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cRE
998			_dz _feng _ggw _h0 _b01/2023 _eb _zSI